Nightstar Therapeutics company
NightstaRx Ltd. is a U.K. startup company. Gene therapy is the use of a gene to treat disease. The approach could enable treatments for a several rare conditions caused by mutations in a single gene.
Technology:
Regenerative Medicine
Industry:
Regenerative Medicine
Headquarters:
London, England, United Kingdom
Founded Date:
7-5
Employees Number:
11-50
Funding Status:
M&A
Investors Number:
4
Total Funding:
$174.6M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership